Immunotherapy Drugs Market
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/525
An increase in the prevalence of cancer and a number of autoimmune diseases, the demand for immunotherapy drugs is likely to increase. Moreover, with the rising need for mAbs, the immunotherapy drugs market is anticipated to have a positive outlook till the end of the forecast period 2016-2024. MAbs have a high affinity towards the specific disease cells as well as areas that require treatment. Accordingly, they can be utilized for therapies such asantibody-directed enzyme prodrug therapy and radio immunotherapy. The increaseduse of these antibodies in the drug development processis likely toaid to boost the market’s revenue making capacity over the forecast period.
Another important factor driving the growth prospects ofthe global immunotherapy drugs market is the materialization of biosimilars. Dissimilarto generic drugs that have active pharmaceutical ingredients alikeoriginal drugs, biosimilars are nearly identical to their creator biologic compounds. In view of the fact that biosimilars are less expensive and aid to make managementof diseases more reachable for the patients than biologics, the sale of biosimilars among the patients and hospitals alike is likely to riseconsiderably during the forecast period thereby augmenting the overall growth of the immunotherapy drugs market.
Immunotherapy Drugs Market Taxonomy
On the basis of product type: Vaccines, mAbs, Non-specific immunotherapies, Immune checkpoint inhibitors,.
On the basis of therapy area: Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, Other Therapy Areas
On the basis of therapy area, the cancer segment is likely to hold the maximum market share in 2016. The large share along with the high growth of this segment is due to the high predilection for immunotherapy as a first line of treatment in the management of cancer thereby leading to rising demand for the global immunotherapy drugs. On the basis of product type, the mAbs segment accounted for the maximum share of the market. The improvement of new drugs as well as the entry of new molecules such as zanolimumab, elotuzumab, onartuzumab, and obinutuzumab into the market will drive the growth of the global immunotherapy drugs market over the forecast period.
Increasing prevalence of cancer and rise in demand from the Asia Pacific region will drive the overall immunotherapy drugsmarket
According to National Cancer Institute, around 1,685,210 new cases of cancer are likely to be diagnosed in the U.S. in 2016 and about 595,690 people are estimated to die from the disease. Since immunotherapy is used as a first line of treatment in the management of cancer, the market immunotherapy drugs market will grow accordingly. North America is the largest region in the global immunotherapy drugs market and is expected to retain its dominance over the forecast period. Asia Pacific is likely to be the fastest-growing marketover the forecast period. The elevated growth of this region can mainly be attributed to low cost of manufacturing of these drugs in the region, rising occurrence of cancer and favorable regulatory framework in this region.
To get holistic SAMPLE with TOC @ https://www.coherentmarketinsights.com/ongoing-insight/toc/525
Some of the companies operating in the immunotherapy drugs market in the current scenario are GlaxoSmithKline, F. Hoffmann-La Roche AG, AbbVie, In., Merck & Co., Inc. Amgen, Inc., Bristol-Myers Squibb, Eli Lilly and Company, Novartis International AG, AstraZeneca plc and Johnson & Johnson.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
1001 4th Ave,
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunotherapy Drugs Market here
News-ID: 1018895 • Views: 319
More Releases from Biotechnology
Global Biotechnology Market Report 2019 Companies included Roche, Pfizer, Merck, …
#7th Edition Biotechnology market report recently has been published by market reports company. It features comprehensive market outlook based on historic data from 2013 to 2018 and estimated market trends during the forecast period from 2018 to 2026. To access complete insights of global Biotechnology market report: firstname.lastname@example.org The Biotechnology market delivers a wide array of primary and secondary data with respect to regional and global market. In-depth analysis of numerous
Epigenetics Market by End Users, and by Geography North America, Latin America, …
Increasing research to study the epigenetics of the genome (study called epigenomics) is expected to boost growth of the epigenetics market over the forecast period. Genome-wide epigenetic studies play an important role in the diagnostics of human diseases. Moreover, implementation of epigenetics for oncology research is estimated to propel the growth of epigenetics market. For instance, Constellation Pharmaceuticals, in April 2018, invested US$ 100 million for development of cancer epigenetics
Industrial Microbiology–Solving Big Issues with Micro Size/Microbial Revolutio …
Advances in fields of Recombinant DNA technology, use of microorganisms in treating diseases, rising prevalence of various bacterial, and viral infections globally is expected to boost the growth of industrial microbiology market with respect to pharmaceutical industry. Use of microorganisms in manufacturing various improvised vaccines for existing as well new infectious diseases is supporting the market growth. Cosmetic industry is growing, owing to the factors, such as evolving lifestyles, increasing
Soft Tissue Repair Market, by Product Type Fixation Products, Tissue Patch,
According to the European Union government legislature, European government will be spending almost 80 billion Euros on Research and Development to enhance a broad range of research projects. According to American Joint Replacement Registry (AJRR), around 75% increase in hospitals was reported and 41% increase in the number of surgeons from the year 2012 -2015, hence there is an increment of 102% in the number of cases related to joint
More Releases for Immunotherapy
Global T-Cell Immunotherapy Market Insights, Forecast
The global T-Cell Immunotherapy market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the T-Cell Immunotherapy market based on company, product type, end user and key regions. This report studies the global market size of T-Cell Immunotherapy in key regions
Immunotherapy Drugs Market Manoeuvre opportunities 2025
Global Immunotherapy Drugs Market: Snapshot Cancer immunotherapy requires the use of a body’s immune system to fight off cancer. The three types of immunotherapies available are passive, active, and hybrid. The core functionality of immunotherapy revolves around the presence of tissue-associated antigens, or TAA’s, which are molecules present on the surface of cancer cells. These are more commonly found as macromolecules such as carbohydrates, or proteins. In the case of active
Immunotherapy Drugs Market
Immunotherapy drugs are used to treat cancer, infection, respiratory and autoimmune disorders. Immunotherapies either stimulate the activities done by specific components of the immune system or counteract the signals that are produced by the cancer cells and suppress the immune responses. The Immunotherapy Drugs Market accounted to USD 107 billion in 2016 growing at a CAGR of 13.2% during the forecast period of 2017 to 2024. The upcoming market report contains
Allergy Treatment Market by Type & Immunotherapy
The global allergy treatment market is characterized by the dominance of a handful companies, namely ALK-Abelló A/S, Sallergenes Greer, and GlaxoSmithKline that hold leading revenue share, states Transparency Market Research (TMR) in a new report. The dominance of these companies is mainly because of their impressive product portfolio and extensive geographical outreach. Some other key names in the global allergy treatment market include Meda Pharmaceuticals Inc., Sunovion Pharmaceuticals Inc., Allergan, Teva
Cancer Immunotherapy Market Cancer Immunotherapy Clinical Pipeline Report 2022
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Immunotherapy: Mending Cancer Regimens 1.1 Preface to Cancer Immunotherapy 1.2 Evolution of Cancer Immunotherapy 2. Categorization of Cancer Immunotherapy 2.1 Specific Cancer Immunotherapy 2.1.1 Cancer Vaccines 2.1.2 Monoclonal Antibodies 2.2 Non-Specific Cancer Immunotherapy 2.2.1 Adoptive Cell Transfer Immunotherapy 2.2.2 Immune Checkpoint Inhibitors 3. Fundamentals
Global Cancer Immunotherapy Market & Cancer Immunotherapy Clinical Trials Outloo …
Pharmaceutical companies are actively engaged in research and development of cancer immunotherapies because of large unmet medical necessities. Investigators are trying to come forth with innovative cancer immunotherapeutic products having high safety and efficacy profiles which are not offered by conventional therapeutics. Higher investments in research and development segment could significantly increase the drug discovery rates which will alleviate the medical condition of cancer patients. Simultaneously, technological advancements are being